iWOW Technology Limited Receives Approval-In-Principle for S\$15 Million Share Placement
Key Developments and Details for Investors
iWOW Technology Limited has announced a significant corporate development that could impact its share price and investor sentiment. On 27 July 2026, the company received the listing and quotation notice (“LQN”) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the proposed allotment and issuance of up to 66,667,000 new Placement Shares at a placement price of S\$0.225 per share.
Highlights of the Placement Exercise
- Maximum Proceeds: The placement, if fully subscribed, will raise up to approximately S\$15 million for iWOW Technology Limited.
- Placement Price: Each new share will be issued at S\$0.225, which may be at a premium or discount to the prevailing market price. Investors should review current market prices to assess potential dilution or accretion.
- Placement Agents: The placement is managed by ZICO Capital Pte. Ltd. as the Placement Agent and Maybank Securities Pte. Ltd. as the Sub-Placement Agent.
- Timeline: The Placement Shares must be placed out within seven (7) market days from the date of the LQN (i.e., by early August 2026), or the approval will lapse.
- SGX-ST Approval: The LQN is an approval-in-principle and is subject to the company’s compliance with all SGX-ST listing requirements. It should not be regarded as an endorsement of the placement, the company, or its securities.
Potential Impact on Shareholders and Share Value
- Share Dilution: The issuance of up to 66,667,000 new shares will increase the total share capital, which may dilute existing shareholders’ holdings and potentially affect the share price.
- Use of Proceeds: While the specific use of funds is not detailed in this announcement, such capital raisings are often intended for business expansion, working capital, or strategic investments. Shareholders should monitor future announcements for more information.
- Uncertainty: There is no certainty or assurance that the Proposed Placement will be completed. Investors should be aware of ongoing risks and await further updates from the company.
- Trading Caution: The company explicitly advises shareholders and potential investors to exercise caution when trading shares, as the placement process is ongoing and subject to completion.
Regulatory Notices and Further Announcements
- Regulatory Status: The Placement Shares are classified as prescribed capital markets products and Excluded Investment Products under Singapore regulations, meaning they may be subject to specific sales and advisory restrictions.
- Further Information: The company will provide additional updates via SGX announcements as and when appropriate.
- Sponsor Review: This announcement has been reviewed by Evolve Capital Advisory Private Limited, the company’s sponsor, but not by the SGX itself.
Key Contacts
For queries, investors may contact Mr. Jerry Chua at Evolve Capital Advisory Private Limited, 160 Robinson Road, #20-01/02, SBF Center, Singapore 068914, Tel: (65) 6241 6626.
Conclusion
The approval-in-principle for a S\$15 million share placement is a material development that could significantly affect iWOW Technology Limited’s strategic direction, capital structure, and share price. Existing and potential investors are strongly encouraged to monitor further company announcements and consult professional advisors before making investment decisions.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult qualified professionals before making investment decisions. The company’s share price may be subject to volatility due to the proposed placement and other market factors.
中文版本
iWOW Technology Limited 获得高达 6,666.7 万股新股配售的原则性批准，拟融资 1,500 万新元
主要亮点和投资者须知
iWOW Technology Limited 于 2026 年 7 月 27 日宣布，公司已收到新加坡交易所（SGX-ST）关于最多 66,667,000 股配售新股（每股配售价 0.225 新元）的上市与报价原则性批准（LQN）。
配售详情及影响
- 最大融资额： 若全部配售完成，公司将筹集约 1,500 万新元。
- 配售价： 每股 0.225 新元，投资者应关注当前市场价以评估潜在稀释或增值影响。
- 配售代理： ZICO Capital Pte. Ltd. 为主配售代理，马来亚银行证券新加坡私人有限公司为副配售代理。
- 配售期限： 新股须在 LQN 日期后的 7 个交易日内完成配售，否则批准将失效。
- 监管提示： LQN 仅为原则性批准，公司还须符合所有上市要求，这不代表对配售、新股或公司本身的认可。
对股东及股价的潜在影响
- 股权稀释： 新股发行后，现有股东持股比例将被稀释，或对股价产生压力。
- 资金用途： 虽未在公告中披露具体用途，通常为业务扩展、运营资金或战略投资。建议关注后续公告。
- 不确定性： 配售未必一定完成，投资者应关注相关风险及后续信息披露。
- 交易提示： 公司明确建议股东和潜在投资者在交易公司股票时保持审慎。
其他监管与后续信息
- 监管分类： 配售新股为受监管的资本市场产品及豁免投资产品，可能受特定销售和建议限制。
- 后续公告： 公司将适时通过交易所公告进一步说明。
- 保荐人审阅： 本公告已由保荐人 Evolve Capital Advisory Private Limited 审阅，但未获新交所审查或批准。
联系方式
如有查询，可联系保荐人负责人 Mr. Jerry Chua，电话：(65) 6241 6626，地址：新加坡罗宾逊路 160 号 #20-01/02，SBF Center，邮编 068914。
结论
此次高达 1,500 万新元的新股配售为公司重大事项，或将影响公司战略、资本结构及股价。建议投资者密切关注后续公告，并在做出投资决策前咨询专业人士。
免责声明： 本文仅供参考，不构成投资建议。投资者应自行进行尽职调查，并在投资前咨询专业人士。公司股价可能因配售及其他市场因素出现波动。
